September 30, 2026 Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection
September 30, 2026 THORNE SETS A HIGHER STANDARD FOR SCIENCE-BACKED WELLNESS WITH NEW CREATINE + ALPHA-GPC CONSUMER RESEARCH SUPPORTING MENTAL AND PHYSICAL PERFORMANCE
September 30, 2026 Dune House Hotel & Spa Unveils Completed Transformation in Atlantic Beach, Florida
